Acute myeloid leukemia: a comprehensive review and 2016 update
I De Kouchkovsky, M Abdul-Hay - Blood cancer journal, 2016 - nature.com
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an
incidence of over 20 000 cases per year in the United States alone. Large chromosomal …
incidence of over 20 000 cases per year in the United States alone. Large chromosomal …
[HTML][HTML] The clinical impact of the molecular landscape of acute myeloid leukemia
S Kayser, MJ Levis - Haematologica, 2023 - ncbi.nlm.nih.gov
Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has
led to remarkable advances in our understanding of the disease. Mutations now allow us to …
led to remarkable advances in our understanding of the disease. Mutations now allow us to …
Functional genomic landscape of acute myeloid leukaemia
The implementation of targeted therapies for acute myeloid leukaemia (AML) has been
challenging because of the complex mutational patterns within and across patients as well …
challenging because of the complex mutational patterns within and across patients as well …
Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology
MS Tallman, ES Wang, JK Altman… - Journal of the National …, 2019 - jnccn.org
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults
and accounts for the largest number of annual deaths due to leukemias in the United States …
and accounts for the largest number of annual deaths due to leukemias in the United States …
Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology
MR O'Donnell, MS Tallman, CN Abboud… - Journal of the National …, 2017 - jnccn.org
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults
and accounts for the largest number of annual deaths due to leukemias in the United States …
and accounts for the largest number of annual deaths due to leukemias in the United States …
Acute myeloid leukemia
Acute Myeloid Leukemia | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
Therapeutic implications of menin inhibition in acute leukemias
GC Issa, F Ravandi, CD DiNardo, E Jabbour… - Leukemia, 2021 - nature.com
Menin inhibitors are novel targeted agents currently in clinical development for the treatment
of genetically defined subsets of acute leukemia. Menin has a tumor suppressor function in …
of genetically defined subsets of acute leukemia. Menin has a tumor suppressor function in …
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
T Herold, M Rothenberg-Thurley, VV Grunwald… - Leukemia, 2020 - nature.com
Abstract The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk
stratification of acute myeloid leukemia have been widely adopted, but have not yet been …
stratification of acute myeloid leukemia have been widely adopted, but have not yet been …
Acute myeloid leukemia: a concise review
JN Saultz, R Garzon - Journal of clinical medicine, 2016 - mdpi.com
Acute myeloid leukemia (AML) is a heterogeneous clonal disorder characterized by
immature myeloid cell proliferation and bone marrow failure. Cytogenetics and mutation …
immature myeloid cell proliferation and bone marrow failure. Cytogenetics and mutation …
OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES
This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …